Literature DB >> 3116575

Public health measures for prevention and control of AIDS.

D R Hopkins1.   

Abstract

The grave challenge posed by the recent pandemic of acquired immunodeficiency syndrome is not the first time mankind has faced such a threat. Useful lessons may be drawn from the successful global Smallpox Eradication Program and applied to the current campaign in the areas of surveillance, strategy, operations, and evaluation. The most important epidemiologic characteristic of this new infection is the unprecedented observation that virtually all asymptomatic infected persons are infectious and will remain so indefinitely. In combatting this infection we should concentrate our efforts in the United States on preventing transmission from the estimated 1.5 million persons who are already infected. We must make the best use we can of all the tools we already have: public information, health education, counseling and serologic testing of persons at high risk, treatment and prevention of intravenous drug abuse, and serologic screening of organ and tissue donors. Adequate confidentiality of test results needs to be secured in order to promote voluntary testing as an important means of achieving behavorial change among persons who are most likely to have been exposed to the infections. Persons whose sexual or drug abuse behavior puts them at higher risk of infection are the highest priority target group. They should be sought at every opportunity, whether seen in public clinics or private practice, and advised to be tested. In order to focus on preventing sexual, parenteral, and perinatal transmission of the virus we must avoid numerous potential distractions and irrelevant issues: we don't have time for them.

Entities:  

Keywords:  Health Care and Public Health; Smallpox Eradication Program

Mesh:

Substances:

Year:  1987        PMID: 3116575      PMCID: PMC1477889     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  3 in total

1.  Prevention of HIV infection.

Authors:  D R Hopkins
Journal:  JAMA       Date:  1987-02-27       Impact factor: 56.272

2.  Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission.

Authors:  J K Kreiss; L W Kitchen; H E Prince; C K Kasper; M Essex
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

3.  Evaluation of heterosexual partners, children, and household contacts of adults with AIDS.

Authors:  M A Fischl; G M Dickinson; G B Scott; N Klimas; M A Fletcher; W Parks
Journal:  JAMA       Date:  1987-02-06       Impact factor: 56.272

  3 in total
  6 in total

Review 1.  AIDS, a social dilemma: detection of seropositives.

Authors:  P Enel; C Manuel; J Charrel; M P Larher; D Reviron; J L San Marco
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

2.  Racial targeting of AIDS programs reconsidered.

Authors:  J T Hernandez; F J Smith
Journal:  J Natl Med Assoc       Date:  1991-01       Impact factor: 1.798

3.  Smallpox: ten years gone.

Authors:  D R Hopkins
Journal:  Am J Public Health       Date:  1988-12       Impact factor: 9.308

4.  Partner notification in the control of human immunodeficiency virus infection.

Authors:  J J Potterat; N E Spencer; D E Woodhouse; J B Muth
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

5.  The ethical approach to AIDS: a bibliographical review.

Authors:  C Manuel; P Enel; J Charrel; D Reviron; M P Larher; X Thirion; J L Sanmarco
Journal:  J Med Ethics       Date:  1990-03       Impact factor: 2.903

Review 6.  Developing strategies for AIDS prevention research with black and Hispanic drug users.

Authors:  R F Schilling; S P Schinke; S E Nichols; L H Zayas; S O Miller; M A Orlandi; G J Botvin
Journal:  Public Health Rep       Date:  1989 Jan-Feb       Impact factor: 2.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.